Search research articles
Contact Us
Filters
Showing results (91-100 of 102) with videos related to
Page
of 11
Sort By:
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
February 10, 2017
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine - Part 2: Immunohistochemistry Test Performance Characteristics
Emina E Torlakovic, Carol C Cheung, Corrado D'Arrigo, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
December 13, 2016
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 4: Tissue Tools for Quality Assurance in Immunohistochemistry
Carol C Cheung, Corrado D'Arrigo, Manfred Dietel, et al.
Journal of Translational Medicine
|
October 21, 2016
Excerpts from the 1st international NTNU symposium on current and future clinical biomarkers of cancer: innovation and implementation, June 16th and 17th 2016, Trondheim, Norway
Ana I Robles, Karina Standahl Olsen, Dana W T Tsui, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
August 6, 2024
Hepatic steatosis and not type 2 diabetes, body mass index, or hepatic fibrosis associates with hyperglucagonemia in individuals with steatotic liver disease
Sasha A S Kjeldsen, Mikkel P Werge, Josephine Grandt, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
April 16, 2024
Patients with autoimmune liver disease have glucose disturbances that mechanistically differ from steatotic liver disease
Anne-Sofie H Jensen, Henriette Ytting, Mikkel P Werge, et al.
Alimentary Pharmacology & Therapeutics
|
July 17, 2025
Diagnostics of Autoimmune Hepatitis Enabled by Non-Invasive Clinical Proteomics
Anne-Sofie Houlberg Jensen, Henriette Ytting, Annelaura Bach Nielsen, et al.
Elife
|
October 3, 2024
Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis
Paul Horn, Jenny Norlin, Kasper Almholt, et al.
Hepatology (Baltimore, Md.)
|
June 24, 2026
Decoding fibrosis: Transcriptomic and clinical insights via AI-derived collagen deposition phenotypes in MASLD
Marta Wojciechowska, Mira Thing, Yang Hu, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
May 3, 2025
Circulating and hepatic levels of growth differentiation factor 15 in patients with metabolic dysfunction-associated steatotic liver disease
Mikkel Parsberg Werge, Josephine Grandt, Mira Thing, et al.
Annals of Hepatology
|
September 1, 2025
Alterations in one-carbon metabolism in metabolic dysfunction associated steatotic liver disease may be modified by semaglutide
Mikkel Parsberg Werge, Adrian McCann, Elias Badal Rashu, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 102) with videos related to
Sort By:
Page
of 11
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
February 10, 2017
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine - Part 2: Immunohistochemistry Test Performance Characteristics
Emina E Torlakovic, Carol C Cheung, Corrado D'Arrigo, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
December 13, 2016
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 4: Tissue Tools for Quality Assurance in Immunohistochemistry
Carol C Cheung, Corrado D'Arrigo, Manfred Dietel, et al.
Journal of Translational Medicine
|
October 21, 2016
Excerpts from the 1st international NTNU symposium on current and future clinical biomarkers of cancer: innovation and implementation, June 16th and 17th 2016, Trondheim, Norway
Ana I Robles, Karina Standahl Olsen, Dana W T Tsui, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
August 6, 2024
Hepatic steatosis and not type 2 diabetes, body mass index, or hepatic fibrosis associates with hyperglucagonemia in individuals with steatotic liver disease
Sasha A S Kjeldsen, Mikkel P Werge, Josephine Grandt, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
April 16, 2024
Patients with autoimmune liver disease have glucose disturbances that mechanistically differ from steatotic liver disease
Anne-Sofie H Jensen, Henriette Ytting, Mikkel P Werge, et al.
Alimentary Pharmacology & Therapeutics
|
July 17, 2025
Diagnostics of Autoimmune Hepatitis Enabled by Non-Invasive Clinical Proteomics
Anne-Sofie Houlberg Jensen, Henriette Ytting, Annelaura Bach Nielsen, et al.
Elife
|
October 3, 2024
Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis
Paul Horn, Jenny Norlin, Kasper Almholt, et al.
Hepatology (Baltimore, Md.)
|
June 24, 2026
Decoding fibrosis: Transcriptomic and clinical insights via AI-derived collagen deposition phenotypes in MASLD
Marta Wojciechowska, Mira Thing, Yang Hu, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
May 3, 2025
Circulating and hepatic levels of growth differentiation factor 15 in patients with metabolic dysfunction-associated steatotic liver disease
Mikkel Parsberg Werge, Josephine Grandt, Mira Thing, et al.
Annals of Hepatology
|
September 1, 2025
Alterations in one-carbon metabolism in metabolic dysfunction associated steatotic liver disease may be modified by semaglutide
Mikkel Parsberg Werge, Adrian McCann, Elias Badal Rashu, et al.
Page
of 11